Cancer Research And Biostatistics
CRAB is a nonprofit organization dedicated to advancing cancer research through clinical trial design, biostatistics, data science, data management, electronic data capture, education, and training. With over 25 years of experience, CRAB collaborates with research networks, pharmaceutical companies, and academic institutions to improve cancer outcomes and develop effective treatments. Its mission is to help conquer cancer and other diseases by providing accurate, timely, and independent research results, fostering collaboration, and supporting innovative methodologies in oncology research.
Industries
Nr. of Employees
medium (51-250)
Cancer Research And Biostatistics
Products
Proprietary electronic data capture platform
A configurable, study-specific EDC platform used to collect and manage clinical and registry data for multicenter studies and consortia projects.
Curated clinical staging and registry databases
Large-scale curated clinical databases created for staging and prognostic research, incorporating harmonized multi-site data for thoracic cancers and related projects.
Proprietary electronic data capture platform
A configurable, study-specific EDC platform used to collect and manage clinical and registry data for multicenter studies and consortia projects.
Curated clinical staging and registry databases
Large-scale curated clinical databases created for staging and prognostic research, incorporating harmonized multi-site data for thoracic cancers and related projects.
Services
Statistical design, analysis, reporting, and methodological consultation for oncology clinical trials across trial phases.
EDC system builds, validation, and study-specific deployments using commercial and proprietary platforms for secure data capture.
Data collection, cleaning, query management, and quality control to prepare datasets for analysis and reporting.
Statistical oversight and meeting management for independent data monitoring committees (DMCs) and data safety monitoring activities.
Remote central monitoring services to assess data quality and identify sites or data elements requiring review.
Workshops and training for investigators, CRAs, and early-stage researchers on clinical trial methods, data practices, and statistical interpretation.
Statistical design, analysis, reporting, and methodological consultation for oncology clinical trials across trial phases.
EDC system builds, validation, and study-specific deployments using commercial and proprietary platforms for secure data capture.
Data collection, cleaning, query management, and quality control to prepare datasets for analysis and reporting.
Statistical oversight and meeting management for independent data monitoring committees (DMCs) and data safety monitoring activities.
Remote central monitoring services to assess data quality and identify sites or data elements requiring review.
Workshops and training for investigators, CRAs, and early-stage researchers on clinical trial methods, data practices, and statistical interpretation.
Expertise Areas
- Clinical trial management
- Biostatistics and statistical methodology
- Electronic data capture and EDC builds
- Data management and quality assurance
Key Technologies
- Electronic Data Capture (EDC) platforms
- Data harmonization and pooled dataset analytics
- Circulating tumor DNA (ctDNA) analysis workflows
- High-dimensional biomarker analytics
News & Updates
CRAB and Fred Hutch Cancer Center have secured funding from the NCI to support the Cancer Screening Research Network (CSRN), aiming to reduce cancer incidence and mortality through multi-center screening trials.
CRAB has collected and analyzed data on over 125,000 lung cancer patients for the IASLC 9th Edition TNM classification, leading to publications and global adoption.
Support for Over 300 Clinical Trials
CRAB has supported more than 300 adult clinical trials, including many large-scale Phase III studies in oncology.
CRAB and Fred Hutch Cancer Center have secured funding from the NCI to support the Cancer Screening Research Network (CSRN), aiming to reduce cancer incidence and mortality through multi-center screening trials.
CRAB has collected and analyzed data on over 125,000 lung cancer patients for the IASLC 9th Edition TNM classification, leading to publications and global adoption.
Support for Over 300 Clinical Trials
CRAB has supported more than 300 adult clinical trials, including many large-scale Phase III studies in oncology.